V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology.

László Sándor Erdélyi, László Hunyady, András Balla

Journal: Frontiers in endocrinology 2023;14():1173601

PMID: 37293495

Abstract

["The diluting and concentrating function of the kidney plays a crucial role in regulating the water homeostasis of the body. This function is regulated by the antidiuretic hormone, arginine vasopressin through the type 2 vasopressin receptor (V2R), allowing the body to adapt to periods of water load or water restriction. Loss-of-function mutations of the V2R cause X-linked nephrogenic diabetes insipidus (XNDI), which is characterized by polyuria, polydipsia, and hyposthenuria. Gain-of-function mutations of the V2R lead to nephrogenic syndrome of inappropriate antidiuresis disease (NSIAD), which results in hyponatremia. Various mechanisms may be responsible for the impaired receptor functions, and this review provides an overview of recent findings about the potential therapeutic interventions in the light of the current experimental data.",{"copyright":"Copyright \u00a9 2023 Erd\u00e9lyi, Hunyady and Balla."}]
Address: Department of Anesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary.; Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; Institute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.; ELKH-SE Laboratory of Molecular Physiology, Eötvös Loránd Research Network, Budapest, Hungary.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.